Proof-of-concept study demonstrates high-throughput screening of titanium-copper alloys using laser powder bed fusion, highlighting ten percent copper as an optimal balance for biomedical use.
The development of novel functional alloys is often constrained by the onerous and costly discovery to validation process. Herein, we present a set-up to enable multi-material production of specimens through in-situ alloy formation using a production laser-based powder bed fusion (PBF-LB) printer. Multi-material samples were achieved through the combined use of a reduced build volume unit, to minimise material requirements (~ 16% powder volume of full build volume), and custom spacers to screen a Ti-Cu biomedical alloy design space allowing for identification of performance thresholds. Multi-material specimens were designed from 0 to 20 wt% Cu in 5% increments and rapidly assessed using high-throughput methods for mechanical and biological properties. Specifically, microhardness and non-destructive ultrasound analysis showcased a significant enhancement in hardness, from 199.24 ± 5.97 to 428.53 ± 26.75 HV, and reduction in longitudinal modulus, from 166.59 ± 4.95 to 148.37 ± 7.54 GPa, as copper content increased. Simultaneously, confocal imaging of pre-osteoblasts (MC3T3s), mesenchymal stem cells (hMSCs), and gram-positive Staphylococcus aureus bacterium after 24 h of contact, suggested 10% Cu as the breakpoint to maintain cytocompatibility and antimicrobial efficacy. Designed Ti-10Cu was identified as the region of interest for further alloy refinement, demonstrating the ability of this screening system to narrow down a material design space according to critical functional properties. This proof-of-concept study presents a feasible alloy discovery tool that utilises a production PBF-LB system without any machine modification.
No takes yet. Share an insight, caveat, or question.
Puzas et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: